Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus

Hepatobiliary and Pancreatic Diseases International

Volumn 11, Issue 3, 2012, Pages 302-306

  Yuan, Jing ^a,b   Yang, Yi ^a   Han, Fei ^a   Zhang, Ping ^a,b   Du, Xiao Ying ^a,b   Jiang, Hua ^a   Chen, Jiang Hua ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Hemodialysis Quality Control Center of Zhejiang Province   (China)

Author keywords

Hemodialysis; Hepatitis B virus; Hepatitis C virus; Infection; Quality control measures

Indexed keywords

ADULT; ARTICLE; CALCULATION; CLINICAL FEATURE; DEATH; DEMOGRAPHY; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUALITY CONTROL; RETROSPECTIVE STUDY; RISK FACTOR; SEROCONVERSION; VIRUS TRANSMISSION;

EID: 84861977096     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(12)60164-7     Document Type: Article

References (24)

1. Lok AS. Chronic hepatitis B. N Engl J Med 2002;346:1682-1683.
2. No authors listed. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001;50:1-43.
3. Almroth G, Ekermo B, Månsson AS, Svensson G, Widell A. Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long-term follow up (1989-January 1997). J Intern Med 2002;251:119-128.
4. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002;36: 3-10.
5. Charest AF, McDougall J, Goldstein MB. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients. Am J Kidney Dis 2000;36:976-982.
6. Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2003;63:2222-2229.
7. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis 2002;35:1368-1375.
8. Schroth RJ, Hitchon CA, Uhanova J, Noreddin A, Taback SP, Moffatt ME, et al. Hepatitis B vaccination for patients with chronic renal failure. Cochrane Database Syst Rev 2004;3: CD003775.
9. Lim WH, Kireta S, Russ GR, Coates PT. Uremia impairs blood dendritic cell function in hemodialysis patients. Kidney Int 2007;71:1122-1131.
10. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
11. Bassit L, Van Heuverswyn H, De Bosschere K, Nishiya AS, Carrilho FJ, Moraes CR, et al. Comparative study of two anti-HCV screening tests in a large genotyped population of Brazilian dialysis patients. Eur J Clin Microbiol Infect Dis 2002;21:404-406.
12. Nakayama E, Akiba T, Marumo F, Sato C. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000;11:1896-1902.
13. Pol S, Samuel D, Cadranel J, Legendre C, Bismuth H, Bréchot C, et al. Hepatitis and solid organ transplantation. Transplant Proc 2000;32:454-457.
14. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl 2008;109:S1-99.
15. Patel PR, Thompson ND, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients. Am J Kidney Dis 2010;56:371-378.
16. Crowley ST. What is the risk of hepatitis C spread within dialysis units and how can we curtail it? Semin Dial 2011;24: 436-438.
17. Li BC, Lu J, Xu J, Ji YF, Cui RL, Su H, et al. HCV Infection in Hemodialysis Patients: Investigation and Prevention. Chin J Nosocomiol 2003;13:329-331.
18. Lanini S, Puro V, Lauria FN, Fusco FM, Nisii C, Ippolito G. Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007. BMC Med 2009;7:15.
19. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004;65:2335-2342.
20. Elamin S, Abu-Aisha H. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations. Arab J Nephrol Transplant 2011;4:35-47.
21. Rahnavardi M, Hosseini Moghaddam SM, Alavian SM. Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Am J Nephrol 2008;28:628-640.
22. Hussein MM, Mooij JM. Methods used to reduce the prevalence of hepatitis C in a dialysis unit. Saudi J Kidney Dis Transpl 2010;21:909-913.
23. Liang XF, Chen YS, Wang XJ, He X, Chen LJ, Wang J, et al. A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old. Zhonghua Liu Xing Bing Xue Za Zhi 2005;26:655-658.
24. Wang C, Sun J, Zhu B, Larsen S, Yu R, Wu J, et al. Hepatitis B virus infection and related factors in hemodialysis patients in China-systematic review and meta-analysis. Ren Fail 2010;32:1255-1264.